切换至 "中华医学电子期刊资源库"

中华腔镜外科杂志(电子版) ›› 2018, Vol. 11 ›› Issue (06) : 335 -338. doi: 10.3877/cma.j.issn.1674-6899.2018.06.006

所属专题: 文献

论著

经阴道自然腔道内镜手术治疗子宫内膜癌的可行性和安全性分析
王延洲1, 姚远洋1, 李宇迪1, 陈诚1, 徐嘉莉1, 梁志清1,()   
  1. 1. 400038 重庆,第三军医大学第一附属医院妇产科
  • 收稿日期:2018-09-25 出版日期:2018-12-30
  • 通信作者: 梁志清
  • 基金资助:
    第三军医大学第一附属医院临床新技术原始创新型重点项目(SWH2016YSCXZD-07)

Natural orifice transvaginal endoscopic surgery for endometrial cancer: feasibility and safety analysis

Yanzhou Wang1, Yuanyang Yao1, Yudi Li1, Cheng Chen1, Jiali Xu1, Zhiqing Liang1,()   

  1. 1. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Third Military Medical University, Chongqing 400038, China
  • Received:2018-09-25 Published:2018-12-30
  • Corresponding author: Zhiqing Liang
  • About author:
    Corresponding author: Liang Zhiqing, Email:
引用本文:

王延洲, 姚远洋, 李宇迪, 陈诚, 徐嘉莉, 梁志清. 经阴道自然腔道内镜手术治疗子宫内膜癌的可行性和安全性分析[J/OL]. 中华腔镜外科杂志(电子版), 2018, 11(06): 335-338.

Yanzhou Wang, Yuanyang Yao, Yudi Li, Cheng Chen, Jiali Xu, Zhiqing Liang. Natural orifice transvaginal endoscopic surgery for endometrial cancer: feasibility and safety analysis[J/OL]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2018, 11(06): 335-338.

目的

探讨经阴道自然腔道内镜手术(transvaginal natural orifice transluminal endoscopic surgery,NOTES)治疗子宫内膜癌的可行性、安全性。

方法

2017年8月至2018年7月前瞻性纳入第三军医大学第一附属医院妇产科诊断为子宫内膜癌的患者,行NOTES。统计患者人口学特征、围手术期参数和临床疗效。

结果

5例患者均成功完成手术。其中2例阴式子宫切除,3例NOTES子宫切除,所有5例附件切除均在NOTES下完成。3例盆腔淋巴结清扫,1例盆腔前哨淋巴结活检,1例盆腔淋巴结清扫+腹主动脉周围淋巴结切除。中位手术时间195 min(130~235 min),中位术中出血量100 ml (50~200 ml),中位术后住院时间5 d(4~9 d)。中位术后肠道功能恢复时间17 h(12~32 h),中位术后12 h疼痛评分1分(1~2分),中位术后24 h疼痛评分1分(1~1分)。术后中位随访时间4个月,所有患者阴道残端切口愈合良好。

结论

NOTES可安全、有效地用于子宫内膜癌全面分期手术,但需要进一步的进行临床研究,评估其完整的临床应用。

Objective

To investigate the feasibility and safety of transvaginal natural endoscopic surgery (NOTES) for endometrial carcinoma.

Methods

From Aug. 2017 to Jul. 2018, patients with endometrial carcinoma were prospectively enrolled in the Department of Obstetrics and Gynecology of the First Affiliated Hospital of Third Military Medical University. Demographic characteristics, perioperative parameters and clinical outcome were statistically analyzed.

Results

All 5 patients were successfully operated. Vaginal hysterectomy was performed in 2 patients, NOTES hysterectomy was performed in 3 patients, and all 5 cases of bilateral salpingo-oophorectomy were performed under NOTES. Pelvic lymphadenectomy was performed in 3 patients, sentinel lymph node biopsy was performed in 1 patient, and pelvic lymphadenectomy plus para-aortic lymphadenectomy was performed in 1 patient. The median operative time was 195 minutes (130-235 minutes), the median blood loss was 100 ml (50-200 ml), and the median postoperative hospital stay was 5 days (4-9 days). The median postoperative recovery time was 17 hours (12-32 hours), the median postoperative 12 hours pain score was 1 (1-2) and the median postoperative 24 hours pain score was 1 (1-1). The median follow-up time were 4 months, the vaginal stump incision healed well in all patients.

Conclusions

NOTES is a safe and effective method for surgical staging of endometrial carcinoma, but further clinical studies are needed to evaluate its complete clinical application.

表1 5例子宫内膜癌患者的一般情况及手术结局
表2 5例子宫内膜癌患者的病理学结局
[1]
Mariani A, Elnashar SA, Dowdy SC. Lymphadenectomy in endometrial cancer: which is the right question[J]. International Journal of Gynecological Cancer Official Journal of the International Gynecological Cancer Society, 2010, 20(2):52-54.
[2]
Kornblith AB, Huang HQ, Walker JL, et al. Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a gynecologic oncology group study[J].J Clin Oncol,2009,27(2):5337-5342.
[3]
Gaia G, Holloway RW, Santoro L, et al. Robotic-assisted hysterectomy for endometrial cancer compared with traditional laparoscopic and laparotomy approaches: a systematic review[J]. Obstetrics & Gynecology, 2010, 116(6):1422-1431.
[4]
Chang WC, Lee LC, Huang SC, et al. Application of laparoscopic surgery in gynecological oncology[J]. Journal of the Formosan Medical Association, 2010, 109(8):558-566.
[5]
Palomba S, Falbo A, Mocciaro R, et al. Laparoscopic treatment for endometrial cancer: a meta-analysis of randomized controlled trials (RCTs)[J]. Gynecologic Oncology, 2009, 112(2):415-421.
[6]
Malzoni M, Tinelli R, Cosentino F, et al. Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study[J]. Gynecologic Oncology, 2009, 112(1):126-133.
[7]
Fanfani F, Fagotti A, Scambia G. Laparoendoscopic single-site surgery for total hysterectomy[J]. International Journal of Gynecology & Obstetrics, 2010, 109(1):76-77.
[8]
Fanfani F, Rossitto C, Gagliardi ML, et al. Total laparoendoscopic singlesite surgery (LESS) hysterectomy in low risk early endometrial cancer: a pilot study[J]. Surg Endosc,2011,26(1):41-46.
[9]
Fagotti A, Bottoni C, Vizzielli G, et al. Postoperative pain after conventional laparoscopy and laparoendoscopic single site surgery (LESS) for benign adnexal disease: a randomized trial[J]. Fertility & Sterility, 2011, 96(1):255-259.
[10]
Escobar PF, Bedaiwy MA, Fader AN, et al. Laparoendoscopic single-site (LESS) surgery in patients with benign adnexal disease[J]. Fertility & Sterility, 2010, 93(6):7-10.
[11]
Boruta DM, Growdon WB, Schorge JO. Single-incision laparoscopic staging for endometrial cancer[J]. Gynecologic Oncology, 2011, 120(1):9-9.
[12]
刘海元,陈欣,孙大为,等.经阴道自然腔道内镜手术在异位妊娠中的应用八例分析[J/CD].中华腔镜外科杂志(电子版),2018,11(1):20-23.
[13]
Lee CL, Wu KY, Su H, et al. Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery (NOTES): a series of 137 patients[J]. Journal of Minimally Invasive Gynecology, 2014, 21(5):818-824.
[14]
Lee CL, Wu KY, Su H, et al. Transvaginal natural-orifice transluminal endoscopic surgery (NOTES) in adnexal procedures[J]. Journal of Minimally Invasive Gynecology, 2012,19(4):509-513.
[15]
张俊吉,戴毅,孙大为,等.经阴道自然腔道内镜手术全子宫切除12例:可行性和安全性分析[J/CD].中华腔镜外科杂志(电子版),2018,11(3):153-156.
[16]
Lee CL, Wu KY, Tsao FY, et al. Natural orifice transvaginal endoscopic surgery for endometrial cancer[J]. Gynecology & Minimally Invasive Therapy, 2014, 3(3):89-92.
[17]
Leblanc E, Narducci F, Bresson L, et al. Fluorescence-assisted sentinel (SND) and pelvic node dissections by single-port transvaginal laparoscopic surgery, for the management of an endometrial carcinoma (EC) in an elderly obese patient[J]. Gynecologic Oncology, 2016,143(3):686-687.
[18]
王延洲,陈诚,徐嘉莉,等. "筷子法"单孔腹腔镜技术在宫颈癌中的应用[J/CD]. 中华腔镜外科杂志(电子版), 2018,11(1):28-31.
[1] 梁志清. 子宫内膜癌微创与个性化治疗的进化与发展[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 621-621.
[2] 戴佑任, 张悦, 李扬, 王聪, 陈婷, 程文俊, 罗成燕. 未分化/去分化子宫内膜癌的临床病理学特征及治疗研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2022, 18(06): 660-668.
[3] 谭佳鸿, 施茹, 赵晗, 张粉, 吴小蝶, 赵琳, 冯云. 经阴道自然腔道内镜手术在妇科良性疾病治疗中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(03): 153-159.
[4] 刘洪云, 李翠, 张海堂, 张玉英, 黄成香. 经脐单孔腹腔镜技术在子宫内膜癌手术中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(03): 182-184.
[5] 王酉, 严斌, 狄文, 楼微华. 经脐单孔腹腔镜前哨淋巴结活检术在早期子宫内膜癌手术中的探讨[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(03): 173-176.
[6] 彭靖, 胡昌东, 华克勤, 陈义松. 经阴道自然腔道内镜下盆底重建术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(01): 9-11.
[7] 周福兴, 贺艳丽, 张潍. 单孔腹腔镜技术在子宫内膜癌全面分期手术中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(01): 55-57.
[8] 陈珂瑶, 柳祎, 孙力. vNOTES全子宫+前哨淋巴结切除治疗Ⅰ期子宫内膜癌[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(01): 21-25.
[9] 杨晓英, 张葛, 徐晓萌, 孙雅欣, 苗月圆, 马迎春. 三种不同腹腔镜入路行大子宫切除术临床疗效评估[J/OL]. 中华腔镜外科杂志(电子版), 2023, 16(06): 331-337.
[10] 王细文, 刘恒炜, 黄桔园, 易跃雄, 张蔚. 单孔腹腔镜UGF两翼法腹主动脉旁淋巴结切除术[J/OL]. 中华腔镜外科杂志(电子版), 2023, 16(04): 246-248.
[11] 黎文娴, 余航, 文芳, 赵文文, 訾聃. 经阴道自然腔道内镜手术在巨大卵巢良性肿瘤中的应用初探[J/OL]. 中华腔镜外科杂志(电子版), 2022, 15(06): 357-363.
[12] 刘燕, 叶亚萍, 郑艳莉. 干扰LINC00466通过miR-493-3p/MIF抑制子宫内膜癌RL95-2细胞恶性生物学行为[J/OL]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 151-158.
[13] 吴迪, 闫志风, 李明霞, 孟元光. 晚期子宫内膜癌免疫治疗的探索[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 231-237.
[14] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J/OL]. 中华临床医师杂志(电子版), 2023, 17(09): 1016-1020.
[15] 殷雨来, 李雪, 何晓阳, 张晓宇. 体质量指数和4种女性特征性癌症的因果关系:一项两样本孟德尔随机化研究[J/OL]. 中华肥胖与代谢病电子杂志, 2023, 09(04): 253-260.
阅读次数
全文


摘要